Dr. Dhiraj Singh is a Staff Scientist at Southwest National Primate Research Center and Texas Biomedical Research Institute working in Tuberculosis (TB) immunology. Dr. Singh’s research is focused on T cell immunity in TB and TB-SIV coinfection and its applications for developing novel immunotherapeutics and vaccines. In the wake of the current COVID-19 pandemic, he is utilizing his expertise and experience in immunology for assessing therapeutic and preventive interventions against COVID-19.